The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Domestic Subgroup Analysis Confirms Efficacy of Cimzia: Astellas, UCB Japan
November 21, 2014
- Kissei Files NDA for Hyperphosphatemia Treatment in Japan
November 21, 2014
- CareNet Teams Up with Indian Firm on Marketing Solutions for Drug Makers
November 20, 2014
- Ranbaxy Sues FDA for Revoking Tentative Approvals for Nexium, Valcyte Generics
November 20, 2014
- Takeda Ordered to Pay US$155,000 for Spoliation of Evidence in Actos Case
November 20, 2014
- Nipro Pharma Joins Hands with Thai Firm on Drug Distribution
November 20, 2014
- Mirena Approved for Dysmenorrhea Based on Data from Public Domain: Bayer Yakuhin
November 20, 2014
- 30% of Pharmacies Handling Blopress AGs Likely to Use Other Makers’ Generics: Survey
November 19, 2014
- Topical Combination Agent for Plaque Psoriasis Showed Superiority to Monotherapies in PIII Trial: Maruho
November 19, 2014
- Giotrif Extends Overall Survival in Japanese NSCLC Patients with Del19 EGFR Mutation: NBI
November 19, 2014
- Valtrex Adult Indications Approved for Children: GSK
November 19, 2014
- Inderal Tablets Approved for Prevention of Hypoxic Episodes: AZ
November 19, 2014
- RaQualia’s Acid Pump Antagonist Enters Domestic PI Study
November 18, 2014
- Diet and Exercise Regimens Weigh on Type 2 Diabetes Patients: MSD Poll
November 18, 2014
- Otsuka Holdings Logs Double-Digit Sales, Profit Rise on Abilify in April-September
November 14, 2014
- Combined Half-Year Sales of Major Japanese Drug Makers Up 2.8% Thanks to Overseas Sales
November 14, 2014
- Gene Techno Science Forms Capital Tie-Up with ORTHOREBIRTH to Codevelop, Market Synthetic Bone
November 14, 2014
- Mediceo Initiates Full-Scale Contract PMS Business to Collect Data from GPs
November 14, 2014
- MTPC Files Radicut for Amyotrophic Lateral Sclerosis
November 14, 2014
- Santen Partners with Singapore Eye Research Institute for Development of New Ophthalmic Drugs
November 14, 2014
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…